Learn more

GEN HOSPITAL CORP

Overview
  • Total Patents
    5,884
  • GoodIP Patent Rank
    3,079
  • Filing trend
    0.0%
About

GEN HOSPITAL CORP has a total of 5,884 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 1980. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are UNIV WASHINGTON, UNIV LELAND STANFORD JUNIOR and UNIV JOHNS HOPKINS.

Patent filings per year

Chart showing GEN HOSPITAL CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Tearney Guillermo J 337
#2 Seed Brian 237
#3 Bouma Brett Eugene 166
#4 Bouma Brett E 162
#5 Ausubel Frederick M 141
#6 Anderson Richard Rox 136
#7 Manstein Dieter 133
#8 Weissleder Ralph 107
#9 Toner Mehmet 103
#10 Romeo Charles 93

Latest patents

Publication Filing date Title
WO2016118593A1 Medical simulation apparatus
AU2015271973A1 Nucleic acid analysis
WO2016081731A1 Systems and methods for obtaining information associated with an anatomical sample using optical microscopy
WO2016081594A1 System and method for photo-dynamic procedure
WO2016077817A1 Methods and compositions for enhancing skin pigmentation
WO2016077595A1 Methods for treating neurodegenerative diseases
WO2016077574A1 INHIBITORS OF MICRORNAs miR-155, miR-103, miR-105 and miR-107 THAT REGULATE PRODUCTION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AS THERAPEUTICS AND USES THEREOF
WO2016077538A1 Syringe infusion pump
CN107406423A Potent gamma secretase modulators
WO2016070074A1 F-18 labeled tracer and methods of manufacture
WO2016065125A1 Method and apparatus for visualizing objects using oblique back-illumination
WO2016065004A1 Methods and devices to study metabolism
WO2016064955A1 Methods of diagnosis and treatment of tuberculosis and infection
WO2016054326A1 Methods for increasing efficiency of nuclease-induced homology-directed repair
WO2016049510A2 Cell-based targeted delivery of pseudonomas exotoxin
WO2016044734A1 Neurodegenerative disease screening using an olfactometer
US2016077169A1 System and Method for Coordinating Use of An Interventional or Implantable Device With External Magnetic Fields
US2016066874A1 Attenuation correction of positron emission tomography data using magnetic resonance images depicting bone density variations
WO2016033160A2 Methods for controlling cell fate and consequences for disease
AU2015218441A1 Methods and Devices for Selective Disruption of Fatty Tissue by Controlled Cooling